Okay, let's tackle this question about glycogen storage diseases and which one doesn't affect muscles. First, I need to recall the different types of glycogen storage diseases (GSDs) and their affected tissues. GSDs are a group of inherited metabolic disorders caused by defects in enzymes involved in glycogen metabolism. Each type is named based on the enzyme deficiency, and they affect different organs like the liver, muscles, or both.

The question is asking which type does NOT affect muscles. So, I need to go through each type. GSD Type I, also known as von Gierke disease, is due to glucose-6-phosphatase deficiency. This enzyme is crucial in the liver for breaking down glycogen into glucose. Since muscles don't store enough glucose-6-phosphate, this disease primarily affects the liver and kidneys, not muscles. That makes it a candidate.

GSD Type II, Pompe disease, is caused by acid alpha-glucosidase deficiency. This enzyme is needed in lysosomes to break down glycogen. It affects both liver and muscles, including the heart, leading to cardiomyopathy. So this one does affect muscles.

GSD Type V, McArdle disease, is due to muscle phosphorylase deficiency. This enzyme is essential for breaking down glycogen in muscles for energy during exercise. So this disease directly affects muscles, causing exercise intolerance.

GSD Type VII, Tarui disease, involves muscle phosphofructokinase deficiency, another key enzyme in glycolysis in muscles. This also leads to muscle symptoms. So Types V and VII affect muscles, while Type I does not.

So the correct answer should be Type I (von Gierke disease). The other options (II, V, VII) all involve muscle involvement. The key point here is that Type I's enzyme deficiency is in the liver, not in muscle cells. The clinical pearl is that Type I is the only GSD without muscle involvement, and it presents with hypoglycemia, hepatomegaly, and lactic acidosis. Students should remember that Type I is purely a liver issue in terms of glycogen metabolism, while others affect muscles due to their reliance on glycolytic enzymes.

**Core Concept** Glycogen storage diseases (GSDs) are inherited metabolic disorders caused by enzyme deficiencies in glycogen metabolism. Muscle involvement depends on whether the defective enzyme is expressed in skeletal/muscle tissue, such as phosphorylase or debranching enzymes.

**Why the Correct Answer is Right** **GSD Type I (von Gierke disease)** results from glucose-6-phosphatase deficiency, which is critical for gluconeogenesis in the liver and kidneys. Since muscle cells lack glucose-6-phosphatase and rely on glycolysis for energy, this enzyme defect does not impair muscle function. Clinical features include fasting hypoglycemia, hepatomegaly, and lactic acidosis but no myopathy.

**Why Each Wrong Option is Incorrect**
**Option B (GSD II/Pompe disease):** Lysosomal alpha-glucosidase deficiency causes glycogen accumulation in heart and skeletal muscles, leading to cardiomyopathy and muscle weakness.
**Option C (GSD V/McArdle disease):** Muscle phosphorylase deficiency directly impairs glycogen breakdown in skeletal muscles, causing exercise intolerance and myoglobinuria

✓ Correct Answer: A. Type 1